A-Z

Distribution in Pharmaceuticals and Biotechnology Partnering Deal Trends Report 2024: Analysis of Agreements Signed Since 2016 Featuring Over 1,500 Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, March 8, 2024

The "Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.
  • Distribution Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter distribution deals with details of distribution deals from 2016 to 2024.
  • The report provides access to distribution deal payment terms as announced between the parties.
  • Contract documents provide an in-depth insight into the actual deal terms agreed between the parties with respect to the distribution deal.

Global Biotechnology Collaboration Agreements Analysis Report 2023 with Directory of Deals Signed Since 2019 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

The report on Collaboration Deals in Biotechnology offers a comprehensive analysis of why and how companies enter collaboration deals in the biotechnology sector.

Key Points: 
  • The report on Collaboration Deals in Biotechnology offers a comprehensive analysis of why and how companies enter collaboration deals in the biotechnology sector.
  • It covers collaboration deals from 2019 to 2023 and provides insights into the payment terms and other specifics of these deals.
  • The report includes a detailed listing of collaboration deals announced since 2019, recorded in the Current Agreements deals and alliances database.
  • Chapter 3 provides insights into the structure of collaboration deals, while chapter 4 reviews the leading collaboration deals since 2019, organized by headline value.

World Biotechnology Licensing Deals Analysis Report 2019-2023 with Directory of Deals by Company A-Z, Therapy Focus and Technology Type - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

The report on Licensing Deals in Biotechnology offers a comprehensive analysis of how and why companies engage in licensing deals within the biotechnology sector.

Key Points: 
  • The report on Licensing Deals in Biotechnology offers a comprehensive analysis of how and why companies engage in licensing deals within the biotechnology sector.
  • The report includes a detailed listing of licensing deals announced since 2019, recorded in the Current Agreements deals and alliances database.
  • Chapter 6 offers a comprehensive and detailed review of licensing deals organized by company A-Z, therapy, technology, and industry type.
  • Licensing Deals in Biotechnology provides the reader with the following key benefits:
    Directory of deals by company A-Z, therapy focus and technology type
    Licensing Deals in Biotechnology includes:
    Analyzing contract agreements allows due diligence of:
    What are the rights granted or optioned?

Global Diagnostics Distribution Deals Analysis Report and Directory 2016-2023 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

The "Distribution Deals in Diagnostics 2016 to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Distribution Deals in Diagnostics 2016 to 2023" report has been added to ResearchAndMarkets.com's offering.
  • Fully revised and updated, the report provides details of distribution deals from 2016 to 2023.
  • Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals.
  • The deal directory includes a comprehensive listing of all distribution deals announced since 2016.

Global Medical Devices Distribution Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

The report on Distribution Deals in Medical Devices offers a comprehensive analysis of why and how companies enter distribution deals in the medical devices sector.

Key Points: 
  • The report on Distribution Deals in Medical Devices offers a comprehensive analysis of why and how companies enter distribution deals in the medical devices sector.
  • It covers distribution deals from 2016 to 2023 and provides insights into the payment terms and other specifics of these deals.
  • The report includes a detailed listing of distribution deals announced since 2016, recorded in the Current Agreements deals and alliances database.
  • Distribution Deals in Medical Devices includes:
    In Distribution Deals in Medical Devices, the available deals are listed by:

Immunology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023

Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the immunology deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the immunology deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of immunology deals from 2016 to 2023.
  • The report also includes numerous table and figures that illustrate the trends and activities in immunology deal making since 2016.
  • Chapter 5 provides a comprehensive and detailed review of immunology deals signed and announced since 2016 where a contract document is available.

Global Hospital Care Collaboration and Licensing Agreements Analysis Report 2023 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023

Fully revised and updated, the report provides details of hospital care deals from 2016 to 2023.

Key Points: 
  • Fully revised and updated, the report provides details of hospital care deals from 2016 to 2023.
  • Hospital Care Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hospital care deals entered into by the worlds leading biopharma companies.
  • The report also includes numerous table and figures that illustrate the trends and activities in hospital care deal making since 2016.
  • Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in hospital care dealmaking.

Autoimmune Collaboration and Licensing Agreements Analysis Report 2023 with a Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023

Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023.

Key Points: 
  • Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023.
  • Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies.
  • The report also includes numerous table and figures that illustrate the trends and activities in autoimmune deal making since 2016.
  • Chapter 5 provides a comprehensive and detailed review of autoimmune deals signed and announced since 2016 where a contract document is available.

Dermatology Collaboration and Licensing Deals Analysis Report and Directory 2016-2023 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023

The "Dermatology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dermatology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.
  • Fully revised and updated, the report provides details of dermatology deals from 2016 to 2023.
  • Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the worlds leading biopharma companies.
  • Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in dermatology dealmaking.

Ophthalmics Collaboration and Licensing Agreements Analysis Report 2023 with a Directory of Deals Signed by the World's Leading Biopharma Companies Since 2016 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023

Fully revised and updated, the report provides details of ophthalmics deals from 2016 to 2023.

Key Points: 
  • Fully revised and updated, the report provides details of ophthalmics deals from 2016 to 2023.
  • Ophthalmics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the ophthalmics deals entered into by the worlds leading biopharma companies.
  • The report also includes numerous table and figures that illustrate the trends and activities in ophthalmics deal making since 2016.
  • Chapter 5 provides a comprehensive and detailed review of ophthalmics deals signed and announced since 2016 where a contract document is available.